BSE filing, BSE: 541299. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lalchandani Labs Ltd: key numbers
- Share price
- ₹7.07
- Market cap
- ₹6.13 Cr
- Revenue (annual)
- ₹4.19 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 96.3×Sector 52.0×
- Promoter holding
- 32.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lalchandani Labs Ltd
All →Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.
Dr. Lalchandani Labs H2 FY26 Results: Net Loss of ₹0.1 Cr
Dr. Lalchandani Labs Ltd reported revenue from operations of ₹2.1 Cr (-8.7% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Dr. Lalchandani Labs Capacity Expansion: ₹1 Cr Investment
Dr Lalchandani Labs opened a new strategic centre in Dwarka, Delhi. The facility targets a ₹1 Crore annual revenue contribution from local government employee residents.
- Value
- ₹1.00 Cr
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs scheduled a board meeting on May 30, 2026, to approve annual audited financial results. The trading window remains closed until June 1.
Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd confirmed it does not meet the 'Large Corporate' criteria for FY 2025-26 under SEBI debt-raising norms. The company reported zero incremental borrowings and no mandatory debt-sourcing requirements as its long-term borrowings remain below the Rs. 1000 crore threshold.
Dr. Lalchandani Labs Debt & Borrowing
Dr Lalchandani Labs Ltd confirmed it does not qualify as a Large Corporate entity for the financial year 2026. The company reported zero outstanding borrowings as of March 31, 2026, and is therefore not subject to SEBI's mandatory debt-raising framework for large entities.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.